| 产品详情 |
| Edit |   |
|---|
| Product Name | Naquotinib |
|---|
| Description | MW: 562.72. Purity ≥98% by HPLC. Naquotinib is a potent; irreversible; third-generation; mutant-selective; epidermal growth factor receptor (EGFR) inhibitor that displays antineoplastic activity. Naquotinib preferentially inhibits mutated forms of EGFR including T790M; a secondarily acquired resistance mutation; and may have therapeutic benefits in tumors with T790M-mediated resistance when compared to other EGFR tyrosine kinase inhibitors. |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [(R)-5- ( (1-acryloylpyrrolidin-3-yl) oxy)-6-ethyl-3- ( (4- (4- (4-methylpiperazin-1-yl) piperidin-1-yl) phenyl) amino) pyrazine-2-carboxamide; ASP8273] |
|---|
| Gene, Accession, CAS # | CAS: 448232-80-1 |
|---|
| Catalog # | MBS846454 |
|---|
| Price | |
|---|
| Order / More Info | Naquotinib from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|